ADVANCEMENT OF CRISPR-BASED ADIPOSE TISSUE THERAPIES FOR TYPE 2 DIABETES TO NONHUMAN PRIMATES

$9,706,177FY2021Defense Health AgencyDOD

University Of Massachusetts Medical School, Worcester MA

Investigators